GNRD yields 2000000.00% · JNJ yields 2.14%● Live data
📍 GNRD pulled ahead of the other in Year 1
Combined, GNRD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GNRD + JNJ for your $10,000?
General Datacomm Industries Inc., through its subsidiaries, designs, develops, manufactures, and markets high-speed network access and transport equipment to provide audio, video, and data transmissions. It offers DSLware and universal xDSL access systems to extend the copper loop, SNMP-based network management systems, IP dynamic mini-routers, TDM over IP gateways, routers and switches, modem security products, remote control/backup products for railroad wayside devices, broadband ATM/MPLS/hybrid/WAN solutions, remote network maintenance products, transportation and wireless connection application products, and blade adapters. It engages in implementations for distributed control systems, and supervisory control and data acquisition networks; and connectivity and internetworking for the healthcare industry. It offers USDA RUS accepted products, including hybrid multiservice access solutions, IP transport and switching products, integrated access devices to consolidate bandwidth requirements, modems/AES encryption products for high speed remote access, and CSUs/DSUs for narrowband and broadband access. It develops and sells infrastructure solutions to carriers and service providers of various types, including RBOCs, PTTs, IXCs, ILECs, IOCs, ISPs, and CLECs; and provides network installation, maintenance plan, extended warranty, operations, enterprise security management, network outsourcing, factory direct repair, and factory direct customer training services. The company's products enable network access, bandwidth management, multiprotocol label switching, voice over IP, Ethernet, and power over Ethernet. It serves carriers and service providers, governments, business enterprises, and commercial end-users in North America, Latin America, and internationally through distributors and resellers in the United States, Canada, Chile, Vietnam, the Russian Federation, and Hong Kong. The company was founded in 1969 and is headquartered in Naugatuck, Connecticut.
Full GNRD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.